Gilead Sciences, Inc.: Gilead Presents Real-World and Long-T

- New Clinical and Patient-Reported Outcomes in People with HIV on Biktarvy in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting - - Long-Term Switch Data

Related Keywords

Norway , California , United States , Iceland , Glasgow , Glasgow City , United Kingdom , Liechtenstein , Foster City , Scotland , Jacquie Ross , Jared Baeten , Brian Plummer , Gilead Sciences , Gilead Sciences Inc , Nasdaq , Exchange Commission , Gilead On Twitter Sciences , Gilead Public Affairs , European Union , European Medicines Agency , Cure Research , Treatment Research , Clinical Development , International Congress On Drug Therapy , Patient Reported Outcomes , Real World Setting , Term Switch Data Further Establish , Durable Efficacy Profile , Data Reinforces , Sustained Efficacy , Twice Yearly Lenacapavir , Multi Drug Resistant , International Congress , Drug Therapy , Vice President , Transformational Innovation , Important Safety Information , Boxed Warnings , European Marketing Authorization , Product Characteristics , Safety Information , Drug Interactions , Antiretroviral Pregnancy Registry , Funders Concerned About , Private Securities Litigation Reform Act , Quarterly Report , Prescribing Information , Gilead , Ciences , Presents , Meal , World , Song , Term , Data , Rom , Research , Programs , 022 ,